DiviDrip · JANX

JANX — Janux Therapeutics, Inc.

JANX is Janux Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $20.24. Market cap: $1.24B. Capital Quality Rank: 53/100 — Above average.

Stock snapshot

Price$20.24
Market cap$1.24B
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)53 / 100 · Above average
ROIC (TTM)-13.8%
Revenue CAGR (3y)5.1%
Shareholder buyback yield-13.26%
Altman Z-score zoneSafe

About JANX

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Listed2021Employees113HQSan Diego, CASectorHealthcareWebsitejanuxrx.com

Related non-dividend companies

Other non-dividend stocks investors research alongside JANX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is JANX's current stock price?

JANX (Janux Therapeutics, Inc.) is currently trading at $20.24.

Does JANX pay a dividend?

JANX (Janux Therapeutics, Inc.) does not currently pay a regular dividend.

What is JANX's Capital Quality Rank?

JANX has a Capital Quality Rank of 53/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track JANX in DiviDrip

Add JANX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow